Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.600
-0.100 (-2.13%)
Aug 14, 2025, 3:21 PM EDT
Veradigm Market Cap
Veradigm has a market cap or net worth of $781.22 million as of August 15, 2025. Its market cap has decreased by -52.30% in one year.
Market Cap
781.22M
Enterprise Value
554.07M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.60
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 781.22M, an increase of 150.54%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 781.22M | -52.74% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | 2.28B | 43.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| Northwest Biotherapeutics | 349.08M |
| American Oncology Network | 337.45M |
| CytoDyn | 300.87M |
| Alterola Biotech | 296.25M |